Bonesupport Holding AB (publ) (STO:BONEX)

Sweden flag Sweden · Delayed Price · Currency is SEK
268.40
+12.40 (4.84%)
Jun 5, 2025, 5:29 PM CET
9.55%
Market Cap 17.68B
Revenue (ttm) 997.85M
Net Income (ttm) 122.34M
Shares Out 65.86M
EPS (ttm) 1.84
PE Ratio 145.96
Forward PE 63.14
Dividend n/a
Ex-Dividend Date n/a
Volume 319,986
Average Volume 233,491
Open 255.20
Previous Close 256.00
Day's Range 253.40 - 270.00
52-Week Range 240.80 - 405.80
Beta 0.66
RSI 45.22
Earnings Date Jul 15, 2025

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t... [Read more]

Sector Healthcare
Founded 1999
Employees 139
Stock Exchange Nasdaq Stockholm
Ticker Symbol BONEX
Full Company Profile

Financial Performance

In 2024, Bonesupport Holding AB's revenue was 898.73 million, an increase of 52.05% compared to the previous year's 591.08 million. Earnings were 133.75 million, a decrease of -45.41%.

Financial Statements

News

There is no news available yet.